Vasoactive intestinal peptide inhibits degranulation and changes granular content of mast cells: A potential therapeutic strategy in controlling septic shock

Peptides

Volumn 21, Issue 1, 2000, Pages 81-89

  Tunçel, Neşe ^a   Töre, Fatma ^a   Sahintürk, Varol ^a   Ak, Dilek ^b   Tunçel, Muzaffer ^b  

^a ESKISEHIR OSMANGAZI UNIVERSITY   (Turkey)

^b ANADOLU UNIVERSITY   (Turkey)

Author keywords

1 Methylhistamine; Antioxidant enzymes; Endotoxic shock; Histamine; Kidney; Lipid peroxidation; Liver; Mast cells; Oxidative stress; Rat; Sepsis; VIP

Indexed keywords

HISTAMINE; HISTAMINE DERIVATIVE; NITRIC OXIDE; VASOACTIVE INTESTINAL POLYPEPTIDE;

ARTICLE; CONTROLLED STUDY; DEGRANULATION; ENZYME ACTIVITY; FEMALE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; LIPID PEROXIDATION; MALE; MAST CELL; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; RAT; SEPSIS; SEPTIC SHOCK; SURVIVAL RATE;

ANIMALS; ANTIOXIDANTS; CATALASE; CELL DEGRANULATION; FEMALE; HISTAMINE; KIDNEY; LIPID PEROXIDATION; LIVER; MALE; MAST CELLS; METHYLHISTAMINES; MICE; NG-NITROARGININE METHYL ESTER; NITRIC OXIDE; RATS; RATS, SPRAGUE-DAWLEY; SHOCK, SEPTIC; SUPEROXIDE DISMUTASE; VASOACTIVE INTESTINAL PEPTIDE;

EID: 0343485005     PISSN: 01969781     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0196-9781(99)00177-1     Document Type: Article

References (63)

1. Aydin Y., Tunçel N., Gürer F., Tunçel M., Kosar M., Oflaz G. Ovarian, uterine and brain mast cells in female rats cyclic changes and contribution to tissue histamine . Comp Biochem Physiol. 120:1998;255-262.
2. Bautista A.P., Spitzer J.J. Inhibition of nitric oxide formation in vivo enhances superoxide release by the perfused liver. Am J Physiol. 266:1994;G783-G788.
3. Berisha H., Foda H.D., Sakakibara H., Trotz M., Pakbaz H., Said S.I. Vasoactive intestinal peptide prevents lung injury due to xanthine/xanthine oxidase. Am J Physiol. 259:1990;L151-L155.
4. Billiar T.R. The delicate balance of nitric oxide and superoxide in liver pathology. Gastroenterology. 108:1995;603-605.
5. Brandzaeg P., Oktadalen O., Kierulf P., Opstad P.K. Elevated VIP and endotoxin plasma levels in human gram-negative septic shock. Regul Pept. 24:1989;37-44.
6. Ching T.L., Koelemij J.G., Bast A. The effect of histamine on the oxidative burst of HL60 cells before and after exposure to reactive oxygen species. Inflamm Res. 44:1995;99-104.
7. Delgado M., Martinez C., Pozo D., Calvo J.R., Leceta J., Ganea D., Gomariz R.P. Vasoactive intestinal peptide (VIP) and pituitary adenylate cyclase-activating polypeptide (PACAP) protect mice from lethal endotoxemia through the inhibition of TNF-α and IL-6. J Immunol. 162:1999;1200-1205.
8. Delgado M., Munoz-Elias E.J., Gomariz R.P., Ganea D. Vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide enhance IL-10 production by murine macrophages in vitro and in vivo studies . J Immunol. 162:1999;1707-1716.
9. Echtenacher B., Mannel D.N., Hulter L. Critical protective role mast cells in a model of acute septic peritonitis. Nature. 381:1996;75-77.
10. Erden S., Tunçel N., Aydin Y., Sahintürk V., Kosar M., Tunçel M. The effect of vasoactive intestinal peptide (VIP) and inhibition of nitric oxide on renal tissue injury of rats exposed to haemorrhagic ischemia and retransfusion a possible interaction mechanism among mast cells and tissue histamine . Ann NY Acad Sci. 865:1998;570-581.
11. Frangogiannis N.G., Lindsey M.L., Michael L.M., Youker K.A., Bressler R.B., Mendoza L.H., Spengler R.N., Smith C.W., Entman M.L. Resident cardiac mast cells degranulate and release preformed TNF-α, initiating the cytokine cascade in experimental canine myocardial ischemia/reperfusion. Circulation. 98:1998;699-710.
12. Fridovich I. Biological effects of superoxide radical. Arch Biochem Biophys. 247:1996;1-11.
13. Fujimoto K., Imamura I., Granger D.N., Wada H., Sakata T., Tso P. Histamine and histidine decarboxylase are correlated with mucosal repair in rat small intestine after ischemia-reperfusion. J Clin Invest. 89:1992;126-133.
14. Fujimoto K., Gotoh Y., Ogata S., Tsunada S., Ohyama T., Ootani A., Okamoto K., Sakata T. Histaminergic control of mucosal repair in the small intestine. Obes Res. 3:1995;795S-799S.
15. Gaboury J.P., Johnston B., Niu X., Kubes P. Mechanisms underlying acute mast cell-induced leukocyte rolling and adhesion in vivo. J Immunol. 154:1995;804-813.
16. Gaboury J.P., Niu X., Kubes P. Nitric oxide inhibits numerous features of mast cell-induced inflammation. Circulation. 93:1996;318-326.
17. Galli J.S. Biology of disease. Lab Invest. 62:1990;6-25.
18. Galli J.S. New concepts about the mast cell. N Engl J Med. 328:1993;257-265.
19. Glick D. Adaptation of polarographic oxygen sensors for biochemical assays. Lessler M.A. Methods of biochemical analysis. Vol. 28:1982;175-199 John Wiley & Sons, New York.
20. Goode H.F., Cowley H.C., Walker B.E., Howdle P.D., Webster N.R. Decreased antioxidant status and increased lipid peroxidation in patients with septic shock and secondary organ dysfunction. Crit Care Med. 23:1994;646-651.
21. Gordon J.R., Burd P.R., Galli S.J. Mast cell as a source of multifunctional cytokines. Immunol Today. 11:1990;458-463.
22. Groeneveld P.H.P., Ringers J., Van Dissel J.T. Effect of nitric oxide on renal function in septic shock. N Engl J Med. 22:1994;1620.
23. Hutcheson I.R., Whittle J.R.B., Boughton-Smith N.K. Role of nitric oxide in maintaining vascular integrity in endotoxin-induced acute intestinal damage in the rat. Br J Pharmacol. 101:1990;815-820.
24. Icho T., Kojima S., Shinohara N., Kajivara Y., Kitabatake K., Kubota K. Protective effects of tetrahydroneopterin against free radical-induced injury. Biochem Pharmacol. 45:1993;1953-1958.
25. Kalfin R., Maulik N., Engelman M.R., Cordis A.G., Milenov K., Kasadov L., Das D.K. Protective role of intracoronary vasoactive intestinal peptide in ischemic and reperfused myocardium. J Pharmacol Exp Ther. 268:1994;952-958.
26. Kanwar S., Wallace J.L., Befus D., Kubes P. Nitric oxide synthesis inhibition increases. epithelial permeability via mast cells. Am J Physiol. 266:1994;G222-G229.
27. Kitamura Y. Heterogeneity of mast cells and phenotypic change between subpopulations. Ann Rev Immunol. 7:1989;56-76.
28. Kostyuk A.V., Potapovich A.I. Superoxide-driven oxidation of quercetine and a simple sensitive assay for determination of superoxide dismutase. Biochem Int. 19:1989;1117-1134.
29. Kubes P., Kanwar S., Niu X., Gaboury J.P. Nitric oxide synthesis inhibition induces leukocyte adhesion via superoxide and mast cells. FASEB J. 7:1993;1293-1299.
30. Kurosawa M.M., Ishizuka T. Inhibitory effects of vasoactive intestinal peptide on superoxide anion formation by n-formyl-methionyl-leucyl-phenylalanine activated inflammatory cells in vitro. Int Arch Allergy Immunol. 100:1993;28-34.
31. Lechner A.J., Velasquez A., Knudsen K., Johanns C.A., Tracy T.F., Matuschak G.M. Cholestatic liver injury increases circulating TNF-α and IL-6 and mortality after Escherichia coli endotoxemia. Am J Respir Crit Care Med. 157:1998;1550-1558.
32. Liaudet L., Rosselet A., Schaller M.D., Markert M., Perret C., Feihl F. Nonselective versus selective inhibition of inducible nitric oxide synthase in experimental endotoxic shock. J Infect Dis. 177:1988;127-132.
33. Llesuy S., Evelson P., Gonzales F.B., Peralta J., Carreras M.C., Poderoso J.J., Boveris A. Oxidative stress in muscle and liver of rats with septic syndrome. Free Rad Biol Med. 16:1994;445-451.
34. Lowry O.H., Rosebrought N.J., Farr A.L., Randal R.J. Protein measurement with the folin phenol reagent. J Biol Chem. 193:1951;265-275.
35. Ma T.T., Ischiropolos H., Brass C.A. Endotoxin-stimulated nitric oxide production increases injury and reduces rat liver chemiluminescence during reperfusion. Gastroenterelogy. 108:1995;463-469.
36. Mannaioni P.F., Masini E., Pistelli A., Salvemini D., Vane J.R. Rat mast cells inhibit platelet aggregation by releasing a nitric oxide-like factor influence of histamine release . New Perspectives in Histamine Research. 1991;423-428 Birkhauser Verlag, Basel.
37. Masini E., Di Bello M.G., Pistelli A., Rasponti S., Gambossi F., Mugnal L., Lugini M., Mannaioni P.F. Generation of nitric oxide from nitrovasodilators modulates the release of histamine from mast cells. J Physiol Pharmacol. 45:1994;41-53.
38. Misra R.B., Misra P.H. Vasoactive intestinal peptide, a singlet oxygen quencher. J Biol Chem. 265:1990;15371-15374.
39. Parrillo J.E. Pathogenetic mechanisms of septic shock. N Engl J Med. 328:1993;1471-1477.
40. Rao N.A. Role of oxygen free radicals in retinal damage associated with experimental uveitis. Trans Ophthalmol Soc. 88:1990;797-850.
41. Revhaug A., Lygren I., Jenssen G.T., Giercksky K.E., Burhol P.G. Vasoactive intestinal peptide in sepsis and shock. Ann NY Acad Sci. 527:1988;536-545.
42. Said SI. Airway smooth muscle, peptide receptors, ion channels, and signal transduction. In: Raeburn D, Giembycz MA, editors. Vasoactive intestinal peptide. Basel: Birkhauser Verlag (chap. 4), 1995. p. 87-113.
43. Said S.I. Vasoactive intestinal peptide and nitric oxide divergent roles in relation to tissue injury . Ann NY Acad Sci. 805:1996;379-387.
44. Sakakibara H., Tkamatsu J., Said S.I. Vasoactive intestinal peptide (VIP) inhibits superoxide anion release from rat alveolar macrophages. Am Rev Respir Dis. 141:1990;A645.
45. Shore P., Burkhalter A., Chon V. A method for the fluorometric assay of histamine in tissues. J Pharmacol Exp Ther. 127:1959;182-184.
46. Steinman U., Estler C.J., Donn O. Plasma histamine levels in rats treated with tryparacidal diamidines. Pharmacology. 36:1988;204-209.
47. Su Z., Ishida H., Fukuyama N., Todorov R., Genka C., Nakazava H. Peroxynitrite is not a major mediator of endothelial cell injury by activated neutrophils in vitro. Cardiovasc Res. 39:1998;485-491.
48. Tepperman B.L., Brown J.F., Korolkiewicz R., Whittle B.J.R. Nitric oxide synthase activity, viability and cyclic GMP levels in rat colonic epithelial cell effect of endotoxin challenge . J Pharmacol Exp Ther. 271:1994;1477-1482.
49. 2-receptor blockers on degranulation. Pharmacology. 43:1991;47-52.
50. Tikiz H., Tunçel N., Akin M.Z., Gürer F. The effect of VIP and naloxone combination on survival rates in rats exposed to severe hemorrhage. Peptides. 13:1992;83-90.
51. Tsunada S., Fujimoto K., Gotoh Y., et al. Role of histamine receptors in intestinal repair after ischemia-reperfusion in rats. Gastroenterology. 107:1994;1297-1304.
52. Tsurata Y., Kohaski K., Ohkura Y. Simultaneous determination of histamine and N-methylhistamine in human urine and rat brain by high-performance liquid chromatography (HPLC) with fluorescence detection. J Chromatogr. 224:1981;105-110.
53. Tunçel N., Gürer F., Aral E., Uzuner K., Aydin Y., Bayçu C. The effect of vasoactive intestinal peptide (VIP) on mast cell invasion/degranulation in testicular interstitium of immobilized + cold stressed and β-endorphin-treated rats. Peptides. 17:1996;817-824.
54. Tunçel N., Basmak H., Uzuner K., Tunçel M., Altiokka G., Zaimoglu V., Özer A., Gürer F. Protection of rat retina from ischemia-reperfusion injury by vasoactive intestinal peptide (VIP) the effect of VIP on lipid peroxidation and antioxidant enzyme activity of retina and choroid . Ann NY Acad Sci. 805:1996;489-498.
55. Tunçel N., Erden S., Uzuner K., Altiokka G., Tunçel M. Ischemic-reperfused rat skeletal muscle the effect of vasoactive intestinal peptide (VIP) on contractile force, oxygenation and antioxidant enzyme systems . Peptides. 18:1996;269-275.
56. Tunçel N., Aydin Y., Kosar M., Tunçel M. The effect of vasoactive intestinal peptide(VIP) on the testicular tissue histamine level of immobilized + cold stressed rats. Peptides. 18:1997;913-915.
57. Tunçel N, Erkasap N, Sahintürk V, Dogrukol Ak D, Tunçel M. The protective effect of vasoactive intestinal peptide (VIP) against stress-induced gastric ulceration in rats. Ann NY Acad Sci 998;865:309-12.
58. Tunçel N., Töre FÇ. The effect of vasoactive intestinal peptide (VIP) and inhibition of nitric oxide synthase on survival rate in rats exposed to endotoxin shock. Ann NY Acad Sci. 865:1998;586-589.
59. Uzuner K., Tunçel N., Aydin Y., Tunçel M., Gürer F., Benli P., Ak D. The effect of vasoactive intestinal peptide (VIP) on superoxide dismutase and catalase activities in renal tissues of rats exposed to hemorrhagic ischemia-reperfusion. Peptides. 16:1995;911-915.
60. Valent P. The riddle of the mast cell kit(CD117)-ligand as the missing link? Immunol Today. 15:1994;11-114.
61. Wang J., Lin S.M. Mixed plant tissue-carbon paste bioelectrode. Anal. Chem. 60:1988;1545-1548.
62. Wollin A. Uptake and methylation of histamine by dispersed gastric mucosal cells and its possible influence on acid secretion. Can J Physiol Pharmacol. 68:1989;71-78.
63. Wrobel-Wagner K., Toborek M., Drozdz M., Danch A. Increase in antioxidant activity in procainamide-treated rats. Pharmacol Toxicol. 72:1993;94-97.